Late relapse of chronic myeloid leukemia after allogeneic stem cell tranplan
Journal Title: OncoReview - Year 2012, Vol 2, Issue 4
Abstract
Chronic myeloid leukemia now is a disease which in the most cases is well manageable with tyrosine kinase inhibitors treatment. Still however the only potentially curable therapeutic approach is for chronic myeloid leukemia allogeneic stem cell transplantation. 30-years old woman was diagnosed as a relapse 18 years after sibling matched donor allotransplantation. After a short cytoreductive treatment imatinib was given in standard dose. Then due to hematological toxicities the dose was diminished to 100 mg. The patient has maintained major molecular response since 2,5 years.
Authors and Affiliations
Ryszard Wichary
Keywords
Related Articles
- EP ID EP53188
- DOI -
- Views 268
- Downloads 0
Retrospective assessment of everolimus treatment in patients suffering from advanced renal cell carcinoma
Objective: Results of second-line everolimus treatment in clear cell renal carcinoma. Material and methods: Clinical data of 32 patients of the Clinic of Systemic and Metastatic Malignancies, Centre of Oncology, Maria...
Ifosfamide-induced encephalopathy in a patient with metastatic fibrosarcoma
Ifosfamide is a cytostatic drug commonly used in chemotherapy. One of the common adverse effects resulting from the treatment with ifosfamide is encephalopathy. This paper describes a case study of a 64-year-old patient...
58-year-old woman with pancreatic neuroendocrine tumour
We reported a 58-year-old woman with tumor in the tail and body of pancreas measuring 70 mm in diameter who underwent distal pancreatectomy and splenectomy. Examination of a specimen of the pancreatic mass obtained histo...
Off-label drug use in breast cancer therapy
Breast cancer is one of the most common malignancies across the world, including Poland. Chemotherapy plays an important part in the treatment of the disease. Most of the available chemotherapy drugs and regimens have un...
Sarcomatoid renal-cell carcinoma: treatment strategy, review of the literature and a case report
Introduction: Sarcomatoid renal-cell carcinoma is a very rare cancer characterised with aggressive course of disease and poor prognosis. At present there are no standards of care for this histologic subtype of renal cell...